SpineX announced today that it enrolled the first patient in its pivotal trial evaluating the Scone neuromodulation device. Los Angeles-based SpineX will evaluate the safety and effectiveness of the non-invasive spinal neuromodulation technology for the treatment of neurogenic bladder. The first patient was enrolled at the Rancho Research Institute of the Rancho Los Amigos National […]
Men's Health
Boston Scientific to acquire majority stake in M.I. Tech
Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech. Marlborough, Massachusetts-based Boston Scientific will acquire a stake totaling approximately 64% in the publicly traded, Korea-based manufacturer and distributor of medical devices for endoscopic and urologic procedures. According to a news release, M.I. Tech created the […]
Bright Uro launches with combined $6M from seed financing, NIH grant
Bright Uro announced its company launch with $6 million in total funding, including a grant from the National Institutes of Health (NIH). Aliso Viejo, California-based Bright Uro aims to transform care for lower urinary tract symptoms (LUTS) with innovations in urodynamics. The company pulled in $4 million in seed financing from Academy Investor Network, surgical […]
DoMore Diagnostics wins CE mark for AI algorithm that predicts colorectal cancer outcomes
DoMore Diagnostics announced that it received CE mark approval in Europe for its Histotype Px Colorectal deep learning algorithm. Oslo, Norway-based DoMore designed its Histotype Px Colorectal deep learning algorithm to predict colorectal cancer patient outcomes based on analysis of digital histology images. The company said in a news release that the algorithm, which builds […]
Teleflex’s UroLift cleared in China to treat BPH
Teleflex (NYSE:TFX) today announced it received National Medical Products Administration (NMPA) approval for its UroLift system in China to treat benign prostatic hyperplasia (BPH). Wayne, Pennsylvania-based Teleflex designed UroLift as a minimally invasive treatment option for lower urinary tract symptoms due to BPH and is indicated in the U.S. for the treatment of an enlarged prostate […]
The road to a robot: Medtronic’s development process for its Hugo RAS system
Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they […]
How Boston Scientific uses clinical feedback to advance innovation
Put simply, the reason most people enter the medtech space is to make a big difference in the lives of patients. However, the process isn’t always straightforward, That’s according to Boston Scientific (NYSE:BSX) SVP of Urology and Pelvic Health Meghan Scanlon. Speaking on the “How Boston Scientific uses clinical feedback to advance innovation” panel at […]
gBETA Medtech accelerator picks its next startups
The gBETA Medtech virtual accelerator today named the five startups that will participate in the spring program leading up to the June 21 showcase day. “We’re so fortunate to have such a diverse set of founders with expertise across the healthcare continuum,” gBETA Medtech Director KC Caine said in a news release. “Our founders are […]
FDA clears J&J’s Ethicon’s Monarch surgical robot for urology procedures
Johnson & Johnson MedTech (NYSE:JNJ) company Ethicon announced today that its Monarch robotic surgery platform received FDA 510(k) clearance. Ethicon’s Auris Health subsidiary received the FDA clearance for Monarch for endourological procedures. Company officials say it’s now the first and only multispecialty, flexible robotic solution for use in both bronchoscopy and urology. The company said […]
Teleflex launches UroLift in Japan
Teleflex (NYSE:TFX) announced today that it launched its UroLift system for treating benign prostatic hyperplasia (BPH) in Japan. Wayne, Pennsylvania–based Teleflex made the UroLift system for BPH or enlarged prostate available for purchase immediately, having recently received reimbursements approval from the Central Social Insurance Medical Council of Japan (Chuikyo). The company designed UroLift as a […]
Medtronic completes first patient implants in implantable tibial neuromodulation trial
Medtronic (NYSE:MDT) announced that it completed the first patient implants in the Titan 2 pivotal study of its investigational neuromodulation device. Fridley, Minnesota-based Medtronic’s Titan 2 trial will evaluate the safety and efficacy of the company’s implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). The company designed the minimally invasive implantable TNM […]
